| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 9.652 | 19.121 | 35.044 | - | 21.909 | 20.939 | 8.309 | 5.173 |
| Total Income - EUR | - | 0 | 29.480 | 38.321 | 54.219 | - | 40.303 | 39.390 | 38.676 | 31.487 |
| Total Expenses - EUR | - | 982 | 28.765 | 37.220 | 43.520 | - | 37.988 | 37.186 | 32.569 | 30.465 |
| Gross Profit/Loss - EUR | - | -982 | 715 | 1.101 | 10.699 | - | 2.316 | 2.205 | 6.107 | 1.022 |
| Net Profit/Loss - EUR | - | -982 | 619 | 910 | 10.349 | - | 2.116 | 1.831 | 5.939 | 747 |
| Employees | - | 0 | 2 | 2 | 2 | - | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Selymed Sam Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 92.426 | 204.900 | 172.937 | 146.250 | - | 95.520 | 73.358 | 50.746 | 28.199 |
| Current Assets | - | 209.283 | 9.208 | 9.178 | 8.475 | - | 23.928 | 2.513 | 11.937 | 21.442 |
| Inventories | - | 48 | 7.190 | 7.247 | 0 | - | 0 | 67 | 67 | 4.087 |
| Receivables | - | 202.305 | 1.605 | 1.570 | 1.106 | - | 1.060 | 66 | 10.399 | 10.449 |
| Cash | - | 6.930 | 413 | 360 | 7.369 | - | 22.868 | 2.380 | 1.471 | 6.906 |
| Shareholders Funds | - | -937 | -303 | 613 | 10.950 | - | 13.731 | 15.605 | 21.497 | 22.123 |
| Social Capital | - | 45 | 44 | 43 | 42 | - | 40 | 41 | 40 | 40 |
| Debts | - | 302.647 | 50.789 | 40.084 | 24.270 | - | 27.865 | 625 | 122 | 4.975 |
| Income in Advance | - | 194.060 | 163.621 | 141.419 | 119.505 | - | 77.851 | 59.641 | 41.065 | 22.543 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Selymed Sam Srl